Organ Recovery Systems Inc.
This article was originally published in Start Up
Organ Recovery Systems Inc. is developing proprietary technologies and protocols designed to address the organ transplant supply-demand imbalance. It hopes to increase the pool of available organs through better assessment of expanded criteria organs, and to use its expertise in cryopreservation to improve the manner in which organs, tissues and cells are recovered, preserved and transported for transplantation.
You may also be interested in...
Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.